Be the new

HR Administrator

in a biotech company focused on the discovery, design and development of innovative peptide-based medicines

Zealand Pharma A/S (Zealand) aims to become a fully integrated biotechnology company leading in delivery of specialty medicines. We are passionate about improving the quality of life for patients with metabolic and gastrointestinal diseases, and other specialty or rare disease areas with significant unmet medical needs.

Zealand is looking for an experienced HR Administrator for a time-limited maternity leave of about 15 months’ duration starting October 1, 2019.

The right candidate is highly experienced in working with HR and recruitment in IT systems and also possesses great knowledge of the Danish Holiday Act.

You will become part of a small HR team of 3 people, but you will have your own area of responsibility.

Job Profile

The successful candidate will be:

Candidate Profile

The successful candidate will have:

What we offer

Zealand’s employees are one of the company’s most important assets. We strive to attract, develop and retain the best talents, and to be a company where every employee can thrive.

At Zealand, we understand the value of a diverse workforce. As an employee, you will be part of an innovative, cross-disciplinary and cross-cultural working environment.

We offer a combined salary package including pension scheme and health insurance, as well as the option of joining the company lunch program, and use of massage, fitness and social facilities.

Location of office: Søborg.

To find out more about working at Zealand, visit our careers site and view our company video at:

www.zealandpharma.com/zealand-as-a-work-place/

www.zealandpharma.com/video-about-zealand-new/

Application

Please apply no later than July 15, 2019.

For further information, please contact Head of HR, Katrine V. Keller
at +45 5060 3735 or kvk@zealandpharma.com


About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq Copenhagen and New York: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of innovative peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on specialty gastrointestinal and metabolic diseases. Zealand’s portfolio also includes two clinical license collaborations with Boehringer Ingelheim and pre-clinical license collaboration with Alexion Pharmaceuticals.

Zealand is based in Copenhagen (Glostrup), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or follow Zealand on LinkedIn or Twitter @ZealandPharma.